Andrew Schutte
Chief Executive Officer at REPLICEL LIFE SCIENCES INC.
Net worth: 779 004 $ as of 2024-03-30
Profile
Andrew Schutte is currently the President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc. He is also the President at Nolan Olbohrung, LLC and Valence Oil LLC.
Previously, he served as the Chief Technology Officer at MainPointe Pharmaceuticals LLC from 2016 to 2022.
Prior to that, he worked as a VBA Programmer at Gerimed, Inc. from 2012 to 2016.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLICEL LIFE SCIENCES INC.
26.77% | 2023-08-15 | 17,401,616 ( 26.77% ) | 765 671 $ | 2024-03-30 |
| 2023-08-15 | 303,030 ( 27.82% ) | 13 333 $ | 2024-03-30 |
Andrew Schutte active positions
| Companies | Position | Start |
|---|---|---|
| REPLICEL LIFE SCIENCES INC. | Chief Executive Officer | 2022-11-27 |
| Nolan Olbohrung, LLC | President | - |
| Valence Oil LLC | President | - |
Former positions of Andrew Schutte
| Companies | Position | End |
|---|---|---|
MainPointe Pharmaceuticals LLC
 MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
| Gerimed, Inc. | Corporate Officer/Principal | 2016-01-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
| RepliCel Life Sciences, Inc. | |
MainPointe Pharmaceuticals LLC
MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Distribution Services |
| Gerimed, Inc. | |
| Nolan Olbohrung, LLC | |
| Valence Oil LLC |
- Stock Market
- Insiders
- Andrew Schutte
